Then, Kaplan–Meier curve analysis showed that PRSS22 expression was associated with OS (overall survival), DSS (Disease Specific Survival), PFI (Progression free interval) in CRC patients (Figure 6H). This evidence concerns the gene PRSS22 and colorectal carcinoma.